Code
01W04218
Looptijd
01-10-2018 → 30-09-2022
Financiering
Regional and community funding: Special Research Fund
Promotor
Onderzoeksdisciplines
-
Natural sciences
- Organic chemistry not elsewhere classified
- Microbiology not elsewhere classified
- Systems biology not elsewhere classified
-
Medical and health sciences
- Laboratory medicine not elsewhere classified
- Microbiology not elsewhere classified
- Laboratory medicine not elsewhere classified
- Laboratory medicine not elsewhere classified
- Microbiology not elsewhere classified
Trefwoorden
Tuberculose
India
Organische synthese
Biologische evaluatie
β-lactamen
Projectomschrijving
Tuberculosis (TB) is an infectious disease responsible for 220.000 deaths per year in India, imposing an immense burden on the country’s health care system. This project aims at establishing an innovative approach in anti-TB therapy by designing β-lactamase inhibitors that could allow classical
β-lactam antibiotics to exert their antibacterial action against (resistant) Mycobacterium tuberculosis strains.